Abstract: According to the present disclosure, it is possible to predict a success or a failure of a clinical trial by reflecting the effect of a drug on a cell population and a human gene. Therefore, it is possible to solve the problems caused by excessive clinical trials, such as excessive use of the drug.

Abstract: A positive electrode active material precursor having a uniform particle size distribution and represented by Formula 1, wherein a percentage of fine powder with an average particle diameter (D50) of 1 ?m or less is generated when the positive electrode active material precursor is rolled at 2.5 kgf/cm2 is less than 1%, and an aspect ratio is 0.93 or more, and a method of preparing the positive electrode active material precursor [NixCoyM1zM2w](OH)2 ??[Formula 1] in Formula 1, 0.5?x<1, 0<y?0.5, 0<z?0.5, and 0?w?0.1, M1 includes at least one selected from the group consisting of Mn and Al, and M2 includes at least one selected from the group consisting of Zr, B, W, Mo, Cr, Nb, Mg, Hf, Ta, La, Ti, Sr, Ba, Ce, F, P, S, and Y. A method of preparing the positive electrode active material precursor is also provided.

Abstract: A secondary battery having improved impact resistance is provided. The secondary battery includes a battery case comprising an electrode assembly and an electrolyte accommodated in an accommodation part of the battery case. The secondary battery satisfies following Equation (1): Equation (1): W/S?42. In Equation (1), W is an amount of electrolyte per unit capacity of the secondary battery [unit: g/Ah], and S is a product of a total length [unit: m] and a full width [unit: m] of the electrode assembly.

Abstract: Provided is a pouch secondary battery. The pouch-type secondary battery may include an electrode assembly and a pouch-type battery case. The pouch-type battery case may include a cup part configured to accommodate the electrode assembly, a pair of first sealing parts disposed at both sides of the cup part perpendicular to a length direction, and a second sealing part configured to connect the pair of first sealing parts to each other and disposed at one side of the cup part perpendicular to a width direction. When an area of the first sealing part is A mm2, and a weight of the electrode assembly is B g, a ratio A/B may be about 0.29 or more.

Abstract: The present invention relates to a urine test container, Specifically, the present invention relates to a container capable of readily separating first urine while receiving whole urine in order to remove the inconvenience of discarding the first urine and putting the remaining urine in a container in a medical institution such as a hospital and a health care institution, because the quality of a test is decreased due to a plurality of epithelial cells included in the first urine in a urine test.

Abstract: The present invention relates to a urine test container, Specifically, the present invention relates to a container capable of readily separating first urine while receiving whole urine in order to remove the inconvenience of discarding the first urine and putting the remaining urine in a container in a medical institution such as a hospital and a health care institution, because the quality of a test is decreased due to a plurality of epithelial cells included in the first urine in a urine test.

Abstract: The present invention provides a shield apparatus for protecting eyeball structures in radiation therapy for a tumor in an eye portion, particularly an eyelid(eyelid) or the conjunctiva. The shield apparatus is a goggle-type patient-customized eyeball shield apparatus for use in radiation therapy, including a pair of lens frames connected by a center connection part, temples, and nose pads. The goggle-type patient-customized eyeball shield apparatus for use in radiation therapy includes the lens frames configured such that open tops are formed by cutting away the upper portions thereof, respectively, and lens grooves are formed along the inner circumferences thereof, respectively; lenses inserted into the respective lens grooves through the open tops; and shields each fastened onto the surface of each of the lenses via any one of a plurality of fastening holes passing through the lens, and configured to shield radiation to be applied to eyeballs.

Abstract: Disclosed is a grouping system using a genotype-based SNS in that, when the peoples having a genotype want to form their community, it provides a means of access to the genotype of an individual's particular position within the limit of a technical security maintenance, so that the social networks is constituted online according to the genetic identity, whereby satisfying personal tastes of the members.

Abstract: Disclosed is a grouping system using a genotype-based SNS in that, when the peoples having a genotype want to form their community, it provides a means of access to the genotype of an individual's particular position within the limit of a technical security maintenance, so that the social networks is constituted online according to the genetic identity, whereby satisfying personal tastes of the members.

Abstract: According to an embodiment of the present invention, an OLED display includes a substrate, a first electrode, a hole transport layer, a hole blocking layer, an emitting layer, and a second electrode. The first electrode is formed on the substrate. The hole transport layer is formed on the first electrode and includes a first material having a first highest occupied molecular orbital (HOMO) level and a first lowest unoccupied molecular orbital (LUMO) level. The hole blocking layer is formed on the hole transport layer and includes a second material having a second HOMO level and a second LUMO level. The emitting layer is formed on the hole blocking layer and includes a third material having a third HOMO level and a third LUMO level. The second electrode is formed on the emitting layer. Herein, the second HOMO level is higher than the first HOMO level and the third HOMO level.

Abstract: According to an embodiment of the present invention, an OLED display includes a substrate, a first electrode, a hole transport layer, a hole blocking layer, an emitting layer, and a second electrode. The first electrode is formed on the substrate. The hole transport layer is formed on the first electrode and includes a first material having a first highest occupied molecular orbital (HOMO) level and a first lowest unoccupied molecular orbital (LUMO) level. The hole blocking layer is formed on the hole transport layer and includes a second material having a second HOMO level and a second LUMO level. The emitting layer is formed on the hole blocking layer and includes a third material having a third HOMO level and a third LUMO level. The second electrode is formed on the emitting layer. Herein, the second HOMO level is higher than the first HOMO level and the third HOMO level.